Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 31

    Lupin gets 5 USFDA observations for Vizag facility

    Lupin gets 5 USFDA observations for Vizag facility

    Medical Dialogues Bureau20 Jan 2020 11:24 AM IST
    The inspection for the API facility at Vizag closed with five 483 observations, Lupin said. New Delhi: Drug firm Lupin on Saturday said it has...
    NCB busts drug racket, over 2 lakh Tramadol tablets, cough syrup seized

    NCB busts drug racket, over 2 lakh Tramadol tablets, cough syrup seized

    Medical Dialogues Bureau20 Jan 2020 11:02 AM IST
    New Delhi: The Narcotics Control Bureau(NCB) has unearthed an inter-state racket of psychotropic medicine traffickers with the seizure of over 7 lakh...
    Drugmajors slash prices by 53pc for China bulk-buy program eligibility

    Drugmajors slash prices by 53pc for China bulk-buy program eligibility

    Medical Dialogues Bureau20 Jan 2020 10:00 AM IST
    Beijing: Global pharmaceutical majors and generic drugmakers chopped by 53% on average prices of some of their off-patent products in the latest...
    ProBioGen, Lava Therapeutics ink agreement for Novel Bispecific Molecule

    ProBioGen, Lava Therapeutics ink agreement for Novel Bispecific Molecule

    Medical Dialogues Bureau20 Jan 2020 9:45 AM IST
    New Delhi: ProBioGen AG and Lava Therapeutics B.V. announced the closing of a cell line development and manufacturing agreement for Lava's novel...
    Kala Pharmaceuticals completes Enrollment of STRIDE 3 Trial for EYSUVIS™  for Dry Eye Disease

    Kala Pharmaceuticals completes Enrollment of STRIDE 3 Trial for EYSUVIS™ for Dry Eye Disease

    Medical Dialogues Bureau19 Jan 2020 10:45 AM IST
    Watertown: Kala Pharmaceuticals, Inc. (Kala), a biopharmaceutical company focused on the development and commercialization of therapeutics using its...
    JnJ Collaborates with The MTV Staying Alive Foundation to Launch health campaigns for Indian Youth

    JnJ Collaborates with The MTV Staying Alive Foundation to Launch health campaigns for Indian Youth

    Medical Dialogues Bureau19 Jan 2020 10:00 AM IST
    Mumbai: Johnson & Johnson Services Inc. has announced its collaboration with the internationally acclaimed social change organization The MTV...
    CIMZIA now approved in Canada for the Treatment of Non-Radiographic Axial Spondyloarthritis

    CIMZIA now approved in Canada for the Treatment of Non-Radiographic Axial Spondyloarthritis

    Medical Dialogues Bureau19 Jan 2020 9:45 AM IST
    Oakville: UCB Canada Inc. announced that Health Canada has approved CIMZIA® (certolizumab pegol) for the treatment of adults with severe active...
    German drug assessment body not convinced by Bayers cancer drug Vitrakvi

    German drug assessment body not convinced by Bayer's cancer drug Vitrakvi

    Medical Dialogues Bureau19 Jan 2020 9:30 AM IST
    Frankfurt: Germany's drug assessment body said that data provided by Bayer on its precision cancer drug Vitrakvi did not provide clear enough evidence...
    Piramal Divests its Healthcare analytics Business for 950 Million USD

    Piramal Divests its Healthcare analytics Business for 950 Million USD

    Medical Dialogues Bureau18 Jan 2020 3:30 PM IST
    India: Piramal Enterprises Limited has announced that PEL DRG Dutch HoldCo BV, a 100% subsidiary of PEL and the holding company for Decision Resources...
    Johnson & Johnson Risperdal Lawsuit: US Court Slashes USD 8 Billion Verdict

    Johnson & Johnson Risperdal Lawsuit: US Court Slashes USD 8 Billion Verdict

    Medical Dialogues Bureau18 Jan 2020 12:17 PM IST
    New York: A Pennsylvania court on Friday slashed a USD 8 billion ruling against US pharmaceutical giant Johnson & Johnson, imposed by a jury...
    Israeli medical imaging firm Nanox raises 26 million dollars

    Israeli medical imaging firm Nanox raises 26 million dollars

    Medical Dialogues Bureau18 Jan 2020 11:59 AM IST
    Tel Aviv: Israeli medical imaging company Nanox Imaging Ltd said on Thursday it raised $26 million with the participation of strategic investor...
    Novo Nordisks Ozempic® gets USFDA for CV risk reduction in people with type 2 diabetes and established CVD

    Novo Nordisk's Ozempic® gets USFDA for CV risk reduction in people with type 2 diabetes and established CVD

    Medical Dialogues Bureau18 Jan 2020 10:36 AM IST
    Denmark: Novo Nordisk has announced that the US Food and Drug Administration (FDA) has approved a label expansion based on a supplemental New...
    PrevNext

    Popular Stories

    Indian Genetics startup MedGenome raises Rs 415 crore in funding led by LeapFrog Investments

    Indian Genetics startup MedGenome raises Rs 415 crore in funding led by LeapFrog Investments

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Lupin gets USFDA EIR for Nagpur Facility

    Lupin gets USFDA EIR for Nagpur Facility

    SMS Pharma updates against USFDA statement on Ranitidine

    SMS Pharma updates against USFDA statement on Ranitidine

    SoftBank leads USD 165 million capital boost for liquid biopsy firm Karius

    SoftBank leads USD 165 million capital boost for liquid biopsy firm Karius

    Philips to ramp up production of ventilators in coronavirus fight

    Philips to ramp up production of ventilators in coronavirus fight

    Shipment of  antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Shipment of antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok